Novel PET Tracer for Perfusion Imaging: What's the Promise?

Flurpiridaz has potential cost, convenience and ― especially for women and obese patients ― efficacy advantages over current PET perfusion methods.

Related Keywords

California , United States , Canada , Stanford University , Denmark , Boston , Massachusetts , Tufts University , American , Jamiesonm Bourque , Michael Salerno , Jamese Udelson , Ge Healthcare , Division Of Cardiology , American Society Of Nuclear Cardiology , Journal Of The American College Cardiology , American College Of Cardiology Imaging Council , University Of Virginia , Drug Administration , Society Of Nuclear Medicine , American Society , Nuclear Cardiology , Nuclear Medicine , Molecular Imaging , American College , Imaging Council , Stress Laboratory , Nuclear Cardiology Laboratory , Tufts University School , Cv , Ardiovascular , Cardiovascular Imaging , Ardiac Imaging , V Imaging , Perfusion Imaging , Atherosclerotic Heart Disease , Therosclerotic Cardiovascular Disease , Oronary Heart Disease , Schemic Heart Disease , Arteries , Restenosis , Athologic Constriction , Stress , Obesity , Bese , Blood , Boards , Smle , Echocardiography , Echocardiogram , Echo , Exercise , Physical Activity , Investment , Leukemia , Positron Emission T ,